D.E. Shaw & Co’s CEL-SCI Corp CVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,774
Closed -$61.7K 4591
2024
Q2
$61.7K Sell
1,774
-4,511
-72% -$192K ﹤0.01% 4203
2024
Q1
$360K Buy
6,285
+2,766
+79% +$196K ﹤0.01% 3642
2023
Q4
$287K Buy
3,519
+2,335
+197% +$145K ﹤0.01% 3762
2023
Q3
$44.4K Sell
1,184
-559
-32% -$26.7K ﹤0.01% 3926
2023
Q2
$126K Buy
1,743
+636
+57% +$46.3K ﹤0.01% 3808
2023
Q1
$77.1K Buy
+1,107
New +$86.6K ﹤0.01% 4001
2022
Q2
Sell
-22,216
Closed -$2.62M 5405
2022
Q1
$2.62M Buy
22,216
+1,368
+7% +$223K ﹤0.01% 3034
2021
Q4
$4.44M Buy
20,848
+4,445
+27% +$1.36M ﹤0.01% 2514
2021
Q3
$5.41M Sell
16,403
-15,384
-48% -$4.49M ﹤0.01% 2040
2021
Q2
$8.28M Sell
31,787
-9,406
-23% -$5.82M 0.01% 1656
2021
Q1
$18.8M Buy
41,193
+11,542
+39% +$6.3M 0.02% 967
2020
Q4
$10.4M Buy
29,651
+342
+1% +$135K 0.01% 1365
2020
Q3
$11.2M Sell
29,309
-1,513
-5% -$597K 0.01% 1174
2020
Q2
$13.8M Buy
30,822
+3,995
+15% +$1.64M 0.02% 1001
2020
Q1
$9.29M Buy
26,827
+21,082
+367% +$7.71M 0.01% 1042
2019
Q4
$1.58M Buy
5,745
+2,708
+89% +$639K ﹤0.01% 2664
2019
Q3
$815K Buy
+3,037
New +$712K ﹤0.01% 2931

Other funds holding CVM

D.E. Shaw & Co's CVM Position: Q3 2024 in Review

D.E. Shaw & Co sold out of CEL-SCI Corp (CVM) in Q3 2024, closing a stake of 1,774 shares — an estimated $61.7K sold.

D.E. Shaw & Co first reported a position in CVM in Q3 2019 and held it in 17 quarters. The position peaked at $18.8M in Q1 2021. 64 funds tracked by Wall St. Rank hold CVM as of Q3 2024.

  • D.E. Shaw & Co reported no remaining CEL-SCI Corp position as of Q3 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,774 CEL-SCI Corp shares in Q3 2024, an estimated $61.7K.
  • D.E. Shaw & Co first reported a position in CEL-SCI Corp in Q3 2019 and held it in 17 quarters.
  • D.E. Shaw & Co's CEL-SCI Corp position peaked at $18.8M in Q1 2021.
  • 64 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q3 2024.

Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.